In this article, we will look at the Top 10 Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing.
Jamie Dimon commented on May 29 at the Reagan National Economic Forum that the market is exuberant but not bad. He believes that the market is exuberant, and exuberance can last a long time, and it is overall not bad. Earnings are up 15-20% this year, and a lot of these companies have huge order books, so it may be justified. There is also hype in other avenues and commodities, and credit spreads are very low. He sees all of these factors as a risk, justifying that while they do make you feel good, if something goes wrong, those asset prices can come down.
READ ALSO: 10 Best Commodity Stocks to Buy for the Supercycle AND 12 Best Small Cap Tech Stocks to Buy According to Hedge Funds.
Dimon also stated that interest rates are a gravity to asset prices, and so it is indeed a risk, but not one he is terrified about. He believes whatever it is can be handled, looking at the risk and the range of potential outcomes. We recently talked about the factors driving record market moves in a recently published article on the 10 Best Momentum Stocks to Buy According to Analysts. Here is an excerpt from the article:
On May 22, Steve Sosnick, from Interactive Brokers, appeared on CNBC’s ‘Power Lunch’ to talk about what is driving the record market moves. Talking about why the market is going high despite the current market dynamics, he said that this is an everything rally, and one of the things that is a hallmark of it is not only the fact that the semis are up 70% in six weeks, which in itself is crazy enough, but rather about what he calls the ratchet effect of the peace dividend. The market is telling us today that they are more concerned about missing some sort of peace in the Middle East than they are about the risks of going home over a three-day weekend.
Sosnick also called for us to think about how we have reacted to any positive news, no matter how remote, about any sort of development in the Middle East that might bring a resolution to this situation. We all want that, but we go up when it is touted, and we do nothing when it doesn’t come out. That, to him, is the ratchet effect.
With these broad market trends in view, let’s look at the top 10 undervalued blue chip stocks analysts recommend for smart investing.
Our Methodology
We used the Finviz stock screener and online sources to identify the best blue chip stocks with a forward P/E below 15 and analyst consensus Moderate to Strong Buy ratings. We then selected the top 10 stocks most popular among hedge funds as of Q1 2026, using the hedge fund sentiment data from Insider Monkey’s database. The stocks are arranged in ascending order of hedge fund sentiment.
Note: All data was recorded on May 29.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
Top 10 Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing
10.Toyota Motor Corporation (NYSE:TM)
Number of Hedge Fund Holders: 20
Toyota Motor Corporation (NYSE:TM) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. Reuters reported on May 28 that, according to a report by Toyota Motor Corporation (NYSE:TM) released on Thursday, the company’s global vehicle sales dropped for a third consecutive month in April, hit primarily by sharp declines in the Middle East and China. It further clarified that global sales fell 3.1% from the prior year period to 849,306 vehicles, while overseas sales dropped 7.5%. However, sales in Japan grew 24.2%, rebounding after earlier purchase delays that took place ahead of an environmental tax change.
Reuters also provided a region-wise breakdown, reporting that sales in the Middle East fell 33.7% to just over 31,000 vehicles and dropped 25.4% in China in a backdrop featuring tough market conditions. Sales in the company’s biggest market, the United States, also dropped 4.6%.
Toyota Motor Corporation further stated that global production grew 2.0% in April compared to the prior year period, with a 12.9% growth in Asia helping offset declines in the U.S. and Japan. The company’s figures include its luxury Lexus brand.
Toyota Motor Corporation manufactures and sells motor vehicles and parts. The company’s operations are divided into the following segments: Automotive, Financial Services, and All Other.
9. Royal Bank of Canada (NYSE:RY)
Number of Hedge Fund Holders: 32
Royal Bank of Canada (NYSE:RY) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. Barclays lifted the price target on Royal Bank of Canada (NYSE:RY) to C$260 from C$245 on May 29, maintaining an Overweight rating on the shares. The rating update came after the bank reported financial results for fiscal Q1 2026 on May 28, with the firm telling investors in a research note that Royal Bank of Canada’s adjusted earnings beat expectations on better-than-anticipated fee income.
In its financial results for the quarter ended April 30, 2026, the company reported net income of $5.5 billion, up $1,119 million or 25% from the previous year. Diluted EPS rose 27% over the same period to $3.85, highlighting growth across each of Royal Bank of Canada’s business segments. Adjusted net income and adjusted diluted EPS for the quarter were $5.6 billion and $3.90, up 23% and 25%, respectively, from the prior year.
Royal Bank of Canada provides banking and financial services. The company’s operations are divided into the following segments: Personal and Commercial Banking, Wealth Management, Insurance, Capital Markets, and Corporate Support.
8. The Toronto-Dominion Bank (NYSE:TD)
Number of Hedge Fund Holders: 33
The Toronto-Dominion Bank (NYSE:TD) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. Barclays lifted the price target on The Toronto-Dominion Bank (NYSE:TD) to C$140 from C$135 on May 29, maintaining an Underweight rating on the shares. The rating update came after the bank reported financial results for fiscal Q2 2026. The Toronto-Dominion Bank also received a rating update from CIBC the same day, with the firm raising the price target on the stock to C$164 from C$151 and maintaining a Neutral rating on the shares.
In its financial results for the quarter ended April 30, 2026, The Toronto-Dominion Bank announced that reported diluted earnings per share were $2.43, compared with $6.27 in the prior year period, while adjusted diluted earnings per share were $2.38, compared to $1.97 in fiscal Q2 2025. Reported net income for the quarter was $4,251 million, compared with $11,129 million, with the adjusted net income reaching $4,168 million, compared with $3,626 million in the prior year period.
The Toronto-Dominion Bank provides financial products and services. Its operations are divided into the following segments: Canadian Personal and Commercial Banking, U.S. Retail, Wealth Management and Insurance, Wholesale Banking, and Corporate segment.
7. T-Mobile US, Inc. (NASDAQ:TMUS)
Number of Hedge Fund Holders: 85
T-Mobile US, Inc. (NASDAQ:TMUS) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. T-Mobile US, Inc. (NASDAQ:TMUS) announced on May 28 a multi-year partnership with the United States Golf Association (USGA), making the company the Official 5G Network Partner of the U.S. Women’s Open, U.S. Open, and additional USGA championships. Management stated that through the partnership, T-Mobile US, Inc. is delivering the USGA’s first-ever mobile Rules Review, critical event connectivity, and exclusive member experiences.
Separately, T-Mobile US, Inc. received several rating updates following the release of its financial results for Q1 on April 28. Scotiabank cut the price target on the stock to $263 from $266 on April 29, reiterating an Outperform rating on the shares and telling investors that it believes the company has responded well to increased promotional intensity.
T-Mobile US, Inc. also received a rating update from BofA the same day. The firm lowered the price target on the stock to $220 from $270, maintaining a Neutral rating on the shares and stating that the company “wrapped up the theme of rational competition and lower device subsidies” for wireless carriers in Q1.
T-Mobile US, Inc. provides wireless communications services under the T-Mobile and MetroPCS brands. The company offers prepaid and postpaid wireless messaging, voice, and data services, along with wholesale wireless services.
6. AbbVie Inc. (NYSE:ABBV)
Number of Hedge Fund Holders: 87
AbbVie Inc. (NYSE:ABBV) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. AbbVie Inc. (NYSE:ABBV) announced on May 29 authorization by the European Commission (EC) for an expanded label for VENCLYXTO® to include use in combination with acalabrutinib (with or without obinutuzumab), along with use in combination with ibrutinib to treat adult patients with previously untreated chronic lymphocytic leukemia (CLL). Management stated that the expanded label follows the EC’s inclusion of these combinations in the acalabrutinib and ibrutinib labels, with all-oral, fixed-duration combination regimens supporting the current standards of care. It added that they can also offer providers and patients additional targeted oral medications for CLL in the first-line setting that include the potential for time off treatment.
AbbVie Inc. further clarified that the European Commission authorization extends to all European Union Member States, and includes Iceland, Norway, and Liechtenstein. Svetlana Kobina, MD, PhD, vice president, global medical affairs, oncology, AbbVie, stated that the VENCLYXTO-based combination regimens exhibited “a favorable efficacy and safety profile in the first-line setting for chronic lymphocytic leukemia”.
AbbVie Inc. is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology, and various other serious health conditions.
5. Merck & Co., Inc. (NYSE:MRK)
Number of Hedge Fund Holders: 98
Merck & Co., Inc. (NYSE:MRK) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. Merck & Co., Inc. announced on May 29 that calderasib (MK-1084), in combination with KEYTRUDA®, which is the company’s anti-PD-1 therapy, has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for the first-line treatment of patients with advanced or metastatic non-small cell lung cancer with KRAS G12C-mutation and expressing PD-L1. Calderasib is an investigational oral specific KRAS G12C inhibitor, and this marks the first Breakthrough Therapy designation for calderasib, supported by positive data from the Phase 1 KANDLELIT-001 trial.
Dr. Shweta Jain, vice president, global clinical development, Merck Research Laboratories, stated that the Breakthrough Therapy designation for calderasib highlights the “promising potential of this medicine and unmet need for certain patients with KRAS G12C-mutated NSCLC.” Merck & Co., Inc. clarified that the FDA’s Breakthrough Therapy designation is granted to accelerate the development and review of medicines intended for the treatment of serious or life-threatening conditions.
Merck & Co., Inc. is a biopharmaceutical company that delivers health solutions to advance the treatment and prevention of diseases in animals and people. Its Pharmaceutical segment offers vaccines and human health pharmaceutical products, typically therapeutic and preventive agents. Its Animal Health segment develops, discovers, manufactures, and markets a range of vaccines and veterinary pharmaceutical products. The company’s medicine KEYTRUDA may treat certain cancers by working with the immune system.
4. Salesforce, Inc. (NYSE:CRM)
Number of Hedge Fund Holders: 101
Salesforce, Inc. (NYSE:CRM) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. DA Davidson cut the price target on Salesforce, Inc. (NYSE:CRM) to $175 from $200 on May 28, maintaining a Neutral rating on the shares. The firm told investors in a research note that the company’s fiscal Q1 earnings represent a strong start to the year. However, it added that despite low investor expectations heading into the quarter, the results and the updated guide did not manage to provide the ammunition for bulls to get more constructive on the name and endorse the top-line acceleration story for the second half of FY27.
Salesforce, Inc. also received a rating update from BMO Capital the same day, with the firm cutting the price target on the stock to $215 from $225 while maintaining an Outperform rating on the shares following the company’s fiscal Q1 results. The firm told investors in a research note that the results and guidance are not likely to be sufficient to convince either bears or bulls to switch sides, and that offer limited changes to FY27 top-line growth expectations.
Salesforce, Inc. designs and develops cloud-based enterprise software for customer relationship management. Its solutions encompass customer service and support, sales force automation, digital commerce, marketing automation, collaboration, community management, industry-specific solutions, and Salesforce platforms. It also offers training, guidance, support, and advisory services.
3. Chevron Corporation (NYSE:CVX)
Number of Hedge Fund Holders: 103
Chevron Corporation (NYSE:CVX) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. On May 26, Barclays lifted the price target on Chevron Corporation (NYSE:CVX) to $213 from $192 and maintained an Equal Weight rating on the shares. It told investors in a research note that factors such as depleting inventories, a “muted” U.S. production response to the Middle East war, and a shrinking OPEC spare capacity are reinforcing a tighter oil macro backdrop that is not fully reflected in equities. These circumstances set up the “oily” exploration and production companies for a share re-rating post the conflict, according to Barclays. The firm also cut its gas price outlook on near-term oversupply while adjusting ratings and price targets in the integrated oil and exploration and production group.
Chevron Corporation also received a rating update from Mizuho on May 27. The firm lifted the price target on the stock to $230 from $225 and reiterated an Outperform rating on the shares, stating that it anticipates prolonged effects of the Iran crisis on global oil prices and refining cracks.
Chevron Corporation provides oil and gas energy solutions, including crude oil and natural gas, the manufacture of transportation fuels, petrochemicals, lubricants, and additives, and the development of technologies that boost business and the industry. Its operations are divided into the Upstream and Downstream segments.
2. Sandisk Corporation (NASDAQ:SNDK)
Number of Hedge Fund Holders: 114
Sandisk Corporation (NASDAQ:SNDK) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. Susquehanna lifted the price target on Sandisk Corporation (NASDAQ:SNDK) to $3,250 from $2,000 on May 29, maintaining a Positive rating on the shares. The firm stated that its checks suggest Q2 DRAM average selling prices are trending to be up 50%-60% quarter-over-quarter, ahead of expectations of up 50%. Meanwhile, NAND ASPs are trending unchanged at up 75-100% quarter-over-quarter. Susquehanna lifted estimates for memory manufacturers under its coverage, driven by growing confidence in the sustainability of the margin profile and the continued strength in blended ASPs.
Sandisk Corporation also received a rating update from Mizuho on May 28, with the firm lifting the price target on the stock to $1,825 from $1,625 while maintaining an Outperform rating on the shares. The firm stated that it increased targets in the semiconductor space after analyzing the memory market and the impact of agentic AI. It further told investors in a research note that it believes DRAM demand will be strong into 2027, as NAND demand is not slowing down, and high bandwidth memory’s total addressable market is growing.
Sandisk Corporation is involved in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. The company’s products include solid-state drives, memory cards, and USB flash drives.
1. Micron Technology, Inc. (NASDAQ:MU)
Number of Hedge Fund Holders: 154
Micron Technology, Inc. (NASDAQ:MU) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. Susquehanna lifted the price target on Micron Technology, Inc. (NASDAQ:MU) to $1,750 from $600 on May 29 and maintained a Positive rating on the shares. The firm stated that its checks suggest Q2 DRAM average selling prices are trending to be up 50%-60% quarter-over-quarter, ahead of expectations of up 50%. Meanwhile, NAND ASPs are trending unchanged at up 75-100% quarter-over-quarter. Susquehanna lifted estimates for memory manufacturers under its coverage, driven by growing confidence in the sustainability of the margin profile and the continued strength in blended ASPs.
In a separate development, Micron Technology, Inc. announced on May 5 that it is now shipping the 245TB capacity Micron® 6600 ION SSD, which marks the highest capacity commercially available SSD in the world. The company stated that the drive is a notable step forward in rack-scale storage density for data centers, specifically designed to support AI, enterprise, cloud, and hyperscale workloads. These include next-generation AI data lakes and cloud-scale file and object storage.
Micron Technology, Inc. provides innovative memory and storage solutions. Its operations are divided into the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU).
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
